Insider Trading
Track Major Insider Updates On X/Twitter
AORT Stock Insider Trading Activity
Corporate insiders are required to disclose purchases or sales of their own stock within two business days of when they occur. Using these disclosures, we collect data on AORT stock insider trading activity, which can give hints on whether Artivion Inc executives are bullish or bearish on their own company.
Recent insider purchases and sales - AORT
| Name / Title | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
|
Holloway Jean F
SVP, General Counsel
|
Sale | 18020 | Mar 11, 2025 | March 12, 2025, 3:41 p.m. |
|
Davis John E
Chief Commercial Officer
|
Sale | 15100 | Mar 11, 2025 | March 12, 2025, 3:32 p.m. |
|
Mackin James P
President & CEO
|
Sale | 70700 | Mar 06, 2025 | March 10, 2025, 5:18 p.m. |
|
Mackin James P
President & CEO
|
Sale | 17739 | Mar 06, 2025 | March 10, 2025, 5:18 p.m. |
|
Horton Amy
VP, Chief Accounting Officer
|
Sale | 1048 | Mar 06, 2025 | March 10, 2025, 5:11 p.m. |
|
Berry Lance A
Executive VP, CFO
|
Sale | 4909 | Mar 06, 2025 | March 10, 2025, 5:08 p.m. |
|
Davis John E
Chief Commercial Officer
|
Sale | 2618 | Mar 06, 2025 | March 10, 2025, 5:06 p.m. |
|
Stanton Marshall S.
SVP, Clinical & MD Affair
|
Sale | 1603 | Mar 06, 2025 | March 10, 2025, 5:03 p.m. |
|
Holloway Jean F
SVP, General Counsel
|
Sale | 2124 | Mar 06, 2025 | March 10, 2025, 5 p.m. |
|
Holloway Jean F
SVP, General Counsel
|
Sale | 472 | Mar 05, 2025 | March 6, 2025, 9:53 a.m. |
|
Horton Amy
VP, Chief Accounting Officer
|
Sale | 814 | Feb 24, 2025 | Feb. 26, 2025, 4:33 p.m. |
|
Horton Amy
VP, Chief Accounting Officer
|
Sale | 485 | Feb 24, 2025 | Feb. 26, 2025, 4:33 p.m. |
|
Horton Amy
VP, Chief Accounting Officer
|
Sale | 1706 | Feb 24, 2025 | Feb. 26, 2025, 4:33 p.m. |
|
Horton Amy
VP, Chief Accounting Officer
|
Sale | 318 | Feb 24, 2025 | Feb. 26, 2025, 4:33 p.m. |
|
Mackin James P
President & CEO
|
Sale | 16664 | Feb 24, 2025 | Feb. 26, 2025, 3 p.m. |
|
Mackin James P
President & CEO
|
Sale | 6812 | Feb 24, 2025 | Feb. 26, 2025, 3 p.m. |
|
Mackin James P
President & CEO
|
Sale | 4896 | Feb 24, 2025 | Feb. 26, 2025, 3 p.m. |
|
Mackin James P
President & CEO
|
Sale | 13784 | Feb 24, 2025 | Feb. 26, 2025, 3 p.m. |
|
Holloway Jean F
SVP, General Counsel
|
Sale | 490 | Feb 24, 2025 | Feb. 26, 2025, 2:57 p.m. |
|
Holloway Jean F
SVP, General Counsel
|
Sale | 2385 | Feb 24, 2025 | Feb. 26, 2025, 2:57 p.m. |
|
Holloway Jean F
SVP, General Counsel
|
Sale | 1650 | Feb 24, 2025 | Feb. 26, 2025, 2:57 p.m. |
|
Holloway Jean F
SVP, General Counsel
|
Sale | 810 | Feb 24, 2025 | Feb. 26, 2025, 2:57 p.m. |
|
Davis John E
Chief Commercial Officer
|
Sale | 2035 | Feb 24, 2025 | Feb. 26, 2025, 2:54 p.m. |
|
Davis John E
Chief Commercial Officer
|
Sale | 985 | Feb 24, 2025 | Feb. 26, 2025, 2:54 p.m. |
|
Davis John E
Chief Commercial Officer
|
Sale | 591 | Feb 24, 2025 | Feb. 26, 2025, 2:54 p.m. |
|
Davis John E
Chief Commercial Officer
|
Sale | 2846 | Feb 24, 2025 | Feb. 26, 2025, 2:54 p.m. |
|
Berry Lance A
Executive VP, CFO
|
Sale | 3259 | Feb 24, 2025 | Feb. 26, 2025, 2:50 p.m. |
|
Stanton Marshall S.
SVP, Clinical & MD Affair
|
Sale | 2299 | Feb 24, 2025 | Feb. 26, 2025, 2:46 p.m. |
|
Stanton Marshall S.
SVP, Clinical & MD Affair
|
Sale | 1246 | Feb 24, 2025 | Feb. 26, 2025, 2:46 p.m. |
|
Stanton Marshall S.
SVP, Clinical & MD Affair
|
Sale | 672 | Feb 24, 2025 | Feb. 26, 2025, 2:46 p.m. |
|
Stanton Marshall S.
SVP, Clinical & MD Affair
|
Sale | 470 | Feb 24, 2025 | Feb. 26, 2025, 2:46 p.m. |
|
Holloway Jean F
SVP, General Counsel
|
Sale | 4035 | Dec 11, 2024 | Dec. 12, 2024, 5:11 p.m. |
|
Holloway Jean F
SVP, General Counsel
|
Sale | 4035 | Dec 11, 2024 | Dec. 12, 2024, 5:11 p.m. |
|
Horton Amy
VP, Chief Accounting Officer
|
Sale | 4329 | Dec 06, 2024 | Dec. 9, 2024, 4:34 p.m. |
|
GREEN ANDREW M
VP Regulatory
|
Sale | 7618 | Dec 04, 2024 | Dec. 4, 2024, 5:11 p.m. |
|
Horton Amy
VP, Chief Accounting Officer
|
Sale | 12430 | Oct 01, 2024 | Oct. 2, 2024, 6:44 p.m. |
|
Holloway Jean F
SVP, General Counsel
|
Sale | 3167 | Aug 26, 2024 | Aug. 27, 2024, 4:47 p.m. |
|
Getz Matthew A
VP, Human Resources
|
Sale | 2562 | Aug 16, 2024 | Aug. 19, 2024, 4:58 p.m. |
|
Getz Matthew A
VP, Human Resources
|
Sale | 6858 | Aug 16, 2024 | Aug. 19, 2024, 4:58 p.m. |
|
Holloway Jean F
SVP, General Counsel
|
Sale | 2383 | Aug 15, 2024 | Aug. 16, 2024, 11:38 a.m. |
|
SEMEDO ANTHONY B.
|
Sale | 9709 | Aug 13, 2024 | Aug. 15, 2024, 10:37 a.m. |
|
Holloway Jean F
SVP, General Counsel
|
Sale | 1250 | May 10, 2024 | May 13, 2024, 6:05 p.m. |
|
Holloway Jean F
SVP, General Counsel
|
Sale | 979 | May 09, 2024 | May 10, 2024, 5:12 p.m. |
|
Stanton Marshall S.
SVP, Clinical & MD Affair
|
Sale | 2183 | Mar 20, 2024 | March 21, 2024, 5:14 p.m. |
|
GREEN ANDREW M
VP Regulatory
|
Sale | 1462 | Mar 15, 2024 | March 18, 2024, 6:09 p.m. |
|
GREEN ANDREW M
VP Regulatory
|
Sale | 3994 | Mar 14, 2024 | March 15, 2024, 5:20 p.m. |
|
Getz Matthew A
VP, Human Resources
|
Sale | 5000 | Mar 12, 2024 | March 14, 2024, 9:06 p.m. |
|
Mackin James P
President & CEO
|
Sale | 13996 | Mar 05, 2024 | March 7, 2024, 7:20 p.m. |
|
Holloway Jean F
SVP, General Counsel
|
Sale | 2380 | Mar 05, 2024 | March 7, 2024, 7:16 p.m. |
|
Davis John E
Chief Commercial Officer
|
Sale | 2022 | Mar 05, 2024 | March 7, 2024, 7:14 p.m. |